What is Bortezomib-dexamethasone (Vd)?

Category: Prescription Drugs

false

See also: Bortezomib

Bortezomib-dexamethasone, also known as Vd, is a regimen that may be used for the treatment of multiple myeloma. It includes bortezomib, an anticancer agent, and dexamethasone, a corticosteroid.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 6
Mild 4
None 7

Commonly reported side effects and conditions associated with Bortezomib-dexamethasone (Vd)

Side effect Patients
Headaches 2
Neuropathic pain in lower extremities 2
Peripheral neuropathy 2
Back pain 1
Back pain when sitting 1
Chronic constipation 1

Show all 14 reported side effects

Dosages

Based on patients currently taking Bortezomib-dexamethasone (Vd)

Dosage Patients
every other week 1
weekly 1

Why patients stopped taking Bortezomib-dexamethasone (Vd)

Multiple reasons could be selected

Reason Patients
Course of treatment ended 5
Doctor's advice 5
Side effects too severe 4
Did not seem to work 1
Other 1
See all 11 patients who've stopped taking Bortezomib-dexamethasone (Vd)

Duration

Currently taking Bortezomib-dexamethasone (Vd)

Duration Patients
2 - 5 years 5
5 - 10 years 1
10 years or more 1

Stopped taking Bortezomib-dexamethasone (Vd)

Duration Patients
Less than 1 month 2
1 - 6 months 4
6 months - 1 year 4
2 - 5 years 1
Adherence
Adherence Evaluations
Always 16
Usually 0
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 3
Not at all hard to take 14
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 2
$25-49 0
< $25 7
Not specified 8

What people switch to and from

Patients started taking Bortezomib-dexamethasone (Vd) after stopping:

Treatment Patients
Bortezomib-lenalidomide-dexamethasone (VRd) 1
Lenalidomide (Revlimid) 1
Lenalidomide-dexamethasone (Rd) 1
Thalidomide-dexamethasone (Td) 1

Patients stopped taking Bortezomib-dexamethasone (Vd) and switched to:

Treatment Patients
Lenalidomide (Revlimid) 1
Pomalidomide (Pomalyst) 1
Last updated:
There are no evaluations for Bortezomib-dexamethasone (Vd).